v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock [Member]
Exchangeable Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss
Accumulated Deficit [Member]
Balance (in shares) at Dec. 31, 2024   12,230,959          
Balance at Dec. 31, 2024 $ 1,272,645 $ 122,308   $ 178,270,782 $ (48,308) $ 0 $ (177,072,137)
Stock-based compensation 1,291,705 $ 0   1,291,705 0 0 0
Restricted shares activity (in shares)   302,600          
Restricted shares activity 0 $ 3,026   (3,026) 0 0 0
Common stock issuance (in shares)   145,554          
Common stock issuance 2,187,176 $ 1,456   2,185,720 0 0 0
Cost of common stock issuance (60,147) $ 0   (60,147) 0 0 0
Shares repurchased for tax withholdings on share-based awards (in shares)   (60,763)          
Shares repurchased for tax withholdings on share-based awards (659,279) $ (608)   (658,671) 0 0 0
Shares issued for convertible debt interest payment (in shares)   17,493          
Shares issued for convertible debt interest payment 199,983 $ 175   199,808 0 0 0
Net income (loss) for the period (6,623,460) $ 0   0 0 0 (6,623,460)
Other comprehensive loss for the period            
Balance (in shares) at Jun. 30, 2025   12,635,843          
Balance at Jun. 30, 2025 (2,391,377) $ 126,357   181,226,171 (48,308) 0 (183,695,597)
Balance (in shares) at Mar. 31, 2025   12,541,962          
Balance at Mar. 31, 2025 (20,503,421) $ 125,418   179,039,931 (48,308) 0 (199,620,462)
Stock-based compensation 759,084 $ 0   759,084 0 0 0
Restricted shares activity (in shares)   16,900          
Restricted shares activity 0 $ 169   (169) 0 0 0
Common stock issuance (in shares)   68,851          
Common stock issuance 1,365,663 $ 689   1,364,974 0 0 0
Cost of common stock issuance (37,556) $ 0   (37,556) 0 0 0
Shares issued for convertible debt interest payment (in shares)   8,130          
Shares issued for convertible debt interest payment 99,988 $ 81   99,907 0 0 0
Net income (loss) for the period 15,924,865 $ 0   0 0 0 15,924,865
Other comprehensive loss for the period            
Balance (in shares) at Jun. 30, 2025   12,635,843          
Balance at Jun. 30, 2025 (2,391,377) $ 126,357   181,226,171 (48,308) 0 (183,695,597)
Balance (in shares) at Dec. 31, 2025   14,968,929          
Balance at Dec. 31, 2025 25,098,289 $ 149,687   238,155,692 (48,308) 0 (213,158,782)
Stock-based compensation 2,334,377 $ 0   2,334,377 0 0 0
Restricted shares activity (in shares)   162,310          
Restricted shares activity 0 $ 1,623   (1,623) 0 0 0
Common stock issuance (in shares)   2,031,355          
Common stock issuance 58,808,399 $ 20,313   58,788,086 0 0 0
Cost of common stock issuance (3,254,133) $ 0   (3,254,133) 0 0 0
Common stock issuance for acquisition, (in shares)   13,786,278          
Common stock issuance for acquisition 229,997,981 $ 137,863   229,860,118 0 0 0
Retraction of exchangeable shares (in shares)   440,548 (440,548)        
Retraction of exchangeable shares 0 $ 4,405   (4,405) 0 0 0
Exercise of options, (in shares)   97,193          
Exercise of options 1,270,283 $ 972   1,269,311 0 0 0
Exercise of pre-funded warrants (in shares)   850,000          
Exercise of pre-funded warrants 8,500 $ 8,500   0 0 0 0
Cancellation of treasury shares (in shares)   (2,480)          
Cancellation of treasury shares 0 $ (25)   (48,283) 48,308 0 0
Exchangeable shares issuance for acquisition 26,658,954     26,658,954 0 0 0
Exchangeable shares issuance for acquisition shares, (in shares)     1,597,301        
Replacement options issuance for acquisition 2,138,173     2,138,173 0 0 0
Shares issued for convertible debt interest payment (in shares)   11,186          
Shares issued for convertible debt interest payment 199,990 $ 112   199,878 0 0 0
Net income (loss) for the period (9,518,603) 0   0 0 0 (9,518,603)
Other comprehensive loss for the period (2,229,538) $ 0   0 0 (2,229,538) 0
Balance (in shares) at Jun. 30, 2026   32,345,319 1,156,753        
Balance at Jun. 30, 2026 331,512,672 $ 323,450   556,096,145 0 (2,229,538) (222,677,385)
Balance (in shares) at Mar. 31, 2026   30,515,252 1,597,301        
Balance at Mar. 31, 2026 321,527,983 $ 305,150   548,735,513 (48,308) 0 (227,464,372)
Stock-based compensation 1,356,314 $ 0   1,356,314 0 0 0
Restricted shares activity (in shares)   162,310          
Restricted shares activity 0 $ 1,623   (1,623) 0 0 0
Common stock issuance (in shares)   176,483          
Common stock issuance 3,231,487 $ 1,765   3,229,722 0 0 0
Cost of common stock issuance (113,340) $ 0   (113,340) 0 0 0
Common stock issuance for acquisition, (in shares)   100,000          
Common stock issuance for acquisition 1,574,000 $ 1,000   1,573,000 0 0 0
Retraction of exchangeable shares (in shares)   440,548 (440,548)        
Retraction of exchangeable shares 0 $ 4,405   (4,405) 0 0 0
Exercise of options, (in shares)   97,193          
Exercise of options 1,270,283 $ 972   1,269,311 0 0 0
Exercise of pre-funded warrants (in shares)   850,000          
Exercise of pre-funded warrants 8,500 $ 8,500   0 0 0 0
Cancellation of treasury shares (in shares)   (2,480)          
Cancellation of treasury shares 0 $ (25)   (48,283) 48,308 0 0
Shares issued for convertible debt interest payment (in shares)   6,013          
Shares issued for convertible debt interest payment 99,996 $ 60   99,936 0 0 0
Net income (loss) for the period 4,786,987 0   0 0 0 4,786,987
Other comprehensive loss for the period (2,229,538) $ 0   0 0 (2,229,538) 0
Balance (in shares) at Jun. 30, 2026   32,345,319 1,156,753        
Balance at Jun. 30, 2026 $ 331,512,672 $ 323,450   $ 556,096,145 $ 0 $ (2,229,538) $ (222,677,385)